We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$3.72B
AUM Growth
+$1.48B
Cap. Flow
+$1.49B
Cap. Flow %
40.14%
Top 10 Hldgs %
94.45%
Holding
734
New
299
Increased
63
Reduced
75
Closed
290

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 0.36%
2 Healthcare 0.2%
3 Industrials 0.19%
4 Energy 0.17%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEHR icon
451
Aehr Test Systems
AEHR
$3.58B
-12,427
Closed -$159K
AHT
452
Ashford Hospitality Trust
AHT
$20.7M
-1,520
Closed -$130K
AM icon
453
CALL
Antero Midstream
AM
$10.4B
-15,600
Closed -$155K
AM icon
454
Antero Midstream
AM
$10.4B
-5,810
Closed -$58K
AMD icon
455
Advanced Micro Devices
AMD
$846B
-7,230
Closed -$859K
AMPY icon
456
Amplify Energy
AMPY
$164M
-15,238
Closed -$70.4K
AMZN icon
457
CALL
Amazon
AMZN
$2.99T
-886,000
Closed -$126M
AMZN icon
458
Amazon
AMZN
$2.99T
-103,140
Closed -$14.7M
AR icon
459
Antero Resources
AR
$11B
-165
Closed -$3.71K
ARKQ icon
460
CALL
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.05B
-100
Closed -$7K
ARKQ icon
461
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.05B
-11,260
Closed -$735K
ASO icon
462
Academy Sports + Outdoors
ASO
$3.02B
-5,543
Closed -$203K
ATOS icon
463
CALL
Atossa Therapeutics
ATOS
$23M
-3,853
Closed -$73K
ATOS icon
464
Atossa Therapeutics
ATOS
$23M
-768
Closed -$15K
AVDL
465
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-17,900
Closed -$100K
AVDL
466
DELISTED
Avadel Pharmaceuticals
AVDL
-3,881
Closed -$22K
AVIR icon
467
CALL
Atea Pharmaceuticals
AVIR
$376M
-14,000
Closed -$90K
AVIR icon
468
Atea Pharmaceuticals
AVIR
$376M
-3,821
Closed -$25K
AXSM icon
469
CALL
Axsome Therapeutics
AXSM
$10.9B
-23,000
Closed -$545K
BALY icon
470
CALL
Bally's
BALY
$664M
-15,400
Closed -$417K
BARK icon
471
CALL
BARK
BARK
$89.6M
-840
Closed -$57K
BATRA icon
472
CALL
Atlanta Braves Holdings Series A
BATRA
$3.52B
-5,600
Closed -$147K
BATRA icon
473
PUT
Atlanta Braves Holdings Series A
BATRA
$3.52B
-4,500
Closed -$118K
BBIO icon
474
CALL
BridgeBio Pharma
BBIO
$16.1B
-15,200
Closed -$157K
BBIO icon
475
BridgeBio Pharma
BBIO
$16.1B
-7,660
Closed -$79K

Similar funds

Belvedere Trading's Q1 2022 Portfolio in Review

As of Q1 2022, Belvedere Trading held 734 positions worth $3.72B, up 66% from $2.24B the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Belvedere Trading deployed $1.49B of net new capital in Q1 2022, opening 299 new positions and adding to 63 existing holdings. Its largest new stake was Tesla: 35,016 shares worth $12M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 0.36% of assets, down from 0.75% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Permian Basin Royalty Trust, an estimated $3.42M trimmed.

  • Belvedere Trading's largest Q1 2022 buy was Tesla: 35,016 shares worth $12M.
  • Belvedere Trading added most to SPDR Gold Trust in Q1 2022, an estimated $25.8M increase.
  • Belvedere Trading's biggest Q1 2022 reduction was Permian Basin Royalty Trust, cutting an estimated $3.42M.
  • Belvedere Trading fully exited State Street SPDR S&P 500 ETF Trust in Q1 2022, selling an estimated $198M.
  • Belvedere Trading's ten largest holdings make up 94% of its $3.72B portfolio in Q1 2022.
  • Belvedere Trading opened 299 new positions and closed 290 in Q1 2022.
  • Belvedere Trading's portfolio value rose 66% quarter-over-quarter to $3.72B.

Based on Belvedere Trading's 13F filing for Q1 2022, filed 20 Apr 2022.